PTC Therapeutics’ results in SMA has Biogen nervous
June 19, 2018Manufacturing and Production, Research and Development Biogen, PTC Therapeutics, biotech, drugs, pharma, pharmaceutical
Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …
FDA rejects Valeant plaque psoriasis lotion over pharmacokinetic concerns
June 19, 2018Manufacturing and Production, Sales and Marketing FDA, Valeant, pharma, psoriasis
Beleaguered pharma firm Valeant has come up against another bump in the road as its plaque psoriasis lotion Duobrii (halobetasol …
Roche buys out rest of Foundation Medicine for $2.4bn
June 19, 2018Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical
Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …
Theranos founder charged with fraud
June 18, 2018Manufacturing and Production, Medical Communications Theranos, biotech, drugs, pharma, pharmaceutical
Going from the youngest female self-made billionaire in the world to being charged with engaging in schemes to defraud investors …
Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute
June 18, 2018Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone
Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …
Maintaining control: The rising challenges of clinical data management
June 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …
HPV vaccine slashes rate of infection by 86% in UK
June 18, 2018Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination
Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …
Teva axes Phase 3 trial into chronic cluster headache
June 18, 2018Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma
With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …
BMS’ Opdivo becomes first immuno-oncology agent available in China
June 18, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma
Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …
£20bn promised to NHS but questions over where money will come from
June 18, 2018Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical
Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …
Top Ten most popular articles on Pharmafile.com this week
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …
Allergan appoints ex-Abbott exec in “Board refreshment” move
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma
Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
New Jersey attempts to lure Teva HQ with tax incentives
June 15, 2018Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …
NICE turns down Roche’s Perjeta for post-surgery HER2-positive breast cancer
June 15, 2018Medical Communications, Sales and Marketing Cancer, NICE, Perjeta, Roche, breast cancer, pharma
Roche’s ongoing dispute with UK health service watchdog NICE over the availability of its monoclonal antibody Perjeta (pertuzumab) on the …
Gene therapy offers hope for those with paralysis
June 15, 2018Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical
Researchers at King’s College London (KCL) have made significant progress to being able to offer a treatment to those with …
Living with childhood dementia
June 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma
Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …
Roche’s Ocrevus extends time-to-wheelchair by 7 years in progressive MS patients
June 14, 2018Research and Development Ocrevus, Roche, multiple sclerosis, pharma
Roche has lifted the curtain on more promising data at Phase 3 for its humanised anti-CD20 monoclonal antibody Ocrevus (ocrelizumab), …
Danger of Sanofi’s dengue vaccine confirmed in new study
June 14, 2018Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical
A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
FDA knocks back Mylan’s Advair generic for second time
June 14, 2018Sales and Marketing Advair, FDA, GSK, Mylan, pharma
The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …
UK immigration rules to be waived to bring in more doctors
June 14, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The NHS’ recruitment crisis has been on-going for a number of years, with an ageing population and a higher workload …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
